Literature DB >> 28749240

Epigenetic dysregulation of the erythropoietic transcription factor KLF1 and the β-like globin locus in juvenile myelomonocytic leukemia.

Silvia Fluhr1, Christopher Felix Krombholz1, Angelina Meier1, Thomas Epting2, Oliver Mücke3, Christoph Plass3,4, Charlotte M Niemeyer1,4, Christian Flotho1,4.   

Abstract

Increased levels of fetal hemoglobin (HbF) are a hallmark of more than half of the children diagnosed with juvenile myelomonocytic leukemia (JMML). Elevated HbF levels in JMML are associated with DNA hypermethylation of distinct gene promoter regions in leukemic cells. Since the regulation of globin gene transcription is known to be under epigenetic control, we set out to study the relation of DNA methylation patterns at β-/γ-globin promoters, mRNA and protein expression of globins, and epigenetic modifications of genes encoding the globin-regulatory transcription factors BCL11A and KLF1 in nucleated erythropoietic precursor cells of patients with JMML. We describe several altered epigenetic components resulting in disordered globin synthesis in JMML. We identify a cis-regulatory upstream KLF1 enhancer sequence as highly sensitive to DNA methylation and frequently hypermethylated in JMML. The data indicate that the dysregulation of β-like globin genes is a genuine attribute of the leukemic cell clone in JMML and involves mechanisms not taking part in the normal fetal-to-adult hemoglobin switch.

Entities:  

Keywords:  Epigenetic regulation; KLF1; fetal hemoglobin; juvenile myelomonocytic leukemia

Mesh:

Substances:

Year:  2017        PMID: 28749240      PMCID: PMC5687323          DOI: 10.1080/15592294.2017.1356959

Source DB:  PubMed          Journal:  Epigenetics        ISSN: 1559-2294            Impact factor:   4.528


  42 in total

Review 1.  Fetal haemoglobin in sickle-cell disease: from genetic epidemiology to new therapeutic strategies.

Authors:  Guillaume Lettre; Daniel E Bauer
Journal:  Lancet       Date:  2016-06-18       Impact factor: 79.321

2.  Foetal erythropoiesis in human leukaemia.

Authors:  D J Weatherall; J B Clegg; W G Wood; S T Callender; B L Sheridan; J Pritchard
Journal:  Nature       Date:  1975-10-23       Impact factor: 49.962

Review 3.  Chronic myelomonocytic leukemia in childhood: a retrospective analysis of 110 cases. European Working Group on Myelodysplastic Syndromes in Childhood (EWOG-MDS)

Authors:  C M Niemeyer; M Arico; G Basso; A Biondi; A Cantu Rajnoldi; U Creutzig; O Haas; J Harbott; H Hasle; G Kerndrup; F Locatelli; G Mann; B Stollmann-Gibbels; E T van't Veer-Korthof; E van Wering; M Zimmermann
Journal:  Blood       Date:  1997-05-15       Impact factor: 22.113

Review 4.  RAS diseases in children.

Authors:  Charlotte M Niemeyer
Journal:  Haematologica       Date:  2014-11       Impact factor: 9.941

5.  RAS mutations and clonality analysis in children with juvenile myelomonocytic leukemia (JMML).

Authors:  C Flotho; S Valcamonica; S Mach-Pascual; G Schmahl; L Corral; J Ritterbach; H Hasle; M Aricò; A Biondi; C M Niemeyer
Journal:  Leukemia       Date:  1999-01       Impact factor: 11.528

6.  A novel, erythroid cell-specific murine transcription factor that binds to the CACCC element and is related to the Krüppel family of nuclear proteins.

Authors:  I J Miller; J J Bieker
Journal:  Mol Cell Biol       Date:  1993-05       Impact factor: 4.272

7.  The patterns of fetal haemoglobin production in leukaemia.

Authors:  B L Sheridan; D J Weatherall; J B Clegg; J Pritchard; W G Wood; S T Callender; I J Durrant; W R McWhirter; M Ali; J W Partridge; E N Thompson
Journal:  Br J Haematol       Date:  1976-04       Impact factor: 6.998

8.  Role of erythroid Kruppel-like factor in human gamma- to beta-globin gene switching.

Authors:  D Donze; T M Townes; J J Bieker
Journal:  J Biol Chem       Date:  1995-01-27       Impact factor: 5.157

9.  Changing erythrocyte populations in juvenile chronic myelocytic leukemia: evidence for disordered regulation.

Authors:  G J Dover; S H Boyer; W H Zinkham; H H Kazazian; D J Pinney; A Sigler
Journal:  Blood       Date:  1977-03       Impact factor: 22.113

10.  Comprehensive characterization of erythroid-specific enhancers in the genomic regions of human Krüppel-like factors.

Authors:  Qian Xiong; Zhaojun Zhang; Kai-Hsin Chang; Hongzhu Qu; Hai Wang; Heyuan Qi; Yajuan Li; Xiuyan Ruan; Yaran Yang; Yadong Yang; Yanming Li; Richard Sandstrom; Peter J Sabo; Qiliang Li; George Stamatoyannopoulos; John A Stamatoyannopoulos; Xiangdong Fang
Journal:  BMC Genomics       Date:  2013-08-28       Impact factor: 3.969

View more
  6 in total

Review 1.  Gene mutations do not operate in a vacuum: the increasing importance of epigenetics in juvenile myelomonocytic leukemia.

Authors:  Christian Flotho
Journal:  Epigenetics       Date:  2019-03-08       Impact factor: 4.528

2.  Exome Sequencing of Fresh-frozen or Formalin-fixed Paraffin-embedded B6C3F1/N Mouse Hepatocellular Carcinomas Arising Either Spontaneously or due to Chronic Chemical Exposure.

Authors:  Scott S Auerbach; Miaofei Xu; B Alex Merrick; Mark J Hoenerhoff; Dhiral Phadke; Debra J Taxman; Ruchir Shah; Hue-Hua L Hong; Thai-Vu Ton; Ramesh C Kovi; Robert C Sills; Arun R Pandiri
Journal:  Toxicol Pathol       Date:  2018-07-25       Impact factor: 1.902

3.  International Consensus Definition of DNA Methylation Subgroups in Juvenile Myelomonocytic Leukemia.

Authors:  Maximilian Schönung; Julia Meyer; Hideki Muramatsu; Christian Flotho; Elliot Stieglitz; Daniel B Lipka; Peter Nöllke; Adam B Olshen; Mark Hartmann; Norihiro Murakami; Manabu Wakamatsu; Yusuke Okuno; Christoph Plass; Mignon L Loh; Charlotte M Niemeyer
Journal:  Clin Cancer Res       Date:  2020-11-02       Impact factor: 13.801

4.  Survey and evaluation of mutations in the human KLF1 transcription unit.

Authors:  Merlin Nithya Gnanapragasam; John D Crispino; Abdullah M Ali; Rona Weinberg; Ronald Hoffman; Azra Raza; James J Bieker
Journal:  Sci Rep       Date:  2018-04-26       Impact factor: 4.379

5.  Comparative targeting analysis of KLF1, BCL11A, and HBG1/2 in CD34+ HSPCs by CRISPR/Cas9 for the induction of fetal hemoglobin.

Authors:  Andrés Lamsfus-Calle; Alberto Daniel-Moreno; Justin S Antony; Thomas Epting; Lukas Heumos; Praveen Baskaran; Jakob Admard; Nicolas Casadei; Ngadhnjim Latifi; Darina M Siegmund; Michael S D Kormann; Rupert Handgretinger; Markus Mezger
Journal:  Sci Rep       Date:  2020-06-23       Impact factor: 4.379

6.  Fetal hemoglobin induction during decitabine treatment of elderly patients with high-risk myelodysplastic syndrome or acute myeloid leukemia: a potential dynamic biomarker of outcome.

Authors:  Julia Stomper; Gabriele Ihorst; Stefan Suciu; Philipp N Sander; Heiko Becker; Pierre W Wijermans; Christoph Plass; Dieter Weichenhan; Emmanuel Bissé; Rainer Claus; Michael Lübbert
Journal:  Haematologica       Date:  2018-08-31       Impact factor: 9.941

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.